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What could ‘fair allocation’ during the COVID-19 crisis possibly mean in sub-Saharan Africa?  
 
The COVID-19 pandemic has reached all continents of the world including Africa. Although 
reported infections in sub-Saharan African low-and-middle-income countries (LMICs) are 
relatively low, they are expected to rise considerably as testing becomes widespread. Many local 
health care systems have been fragile for decades and struggling to meet existing health needs, 
and are likely to be rapidly overwhelmed if large surges of critically ill patients arrive. The COVID-
19 pandemic is particularly challenging as the SARS-CoV-2 is easily transmitted through 
respiratory droplets, including by asymptomatic persons, while a vaccine or effective treatment 
are unavailable. In low-income African countries suffering from chronic shortages in health care 
resources, and high morbidity and mortality from non-COVID-19 causes such as HIV and TB, what 
are the key clinical and public health ethics challenges raised by the COVID-19 pandemic, and 
what room is there for an ethical response? We argue that context matters when it comes to 
COVID-19 ethical recommendations, and talk of ‘fair allocation’ of resources has a very hollow 
ring in settings long familiar with rationing and marked by high disease burdens, poverty, and 
social injustice.    
 
As a point of departure, the success of any public health measure is anchored in prevention. To 
be ethically justified, measures must be effective.1 Effectiveness presupposes feasibility. The 
recommendation by World Health Organisation (WHO) for physical distancing of at least a metre 
is no doubt evidence-based as a means of reducing transmission of a severe respiratory illness 
with droplet spread. But its feasibility is highly questionable in urban slums, informal settlements, 
refugee camps and homeless shelters. Africa is home to many settings of dense human spaces 
much better suited to fueling the spread of disease than containing it. In settings of generalized 
insecurity, where people must venture outside for potable water, sanitary needs, and their daily 
food rations, well-intentioned recommendations to stay home is a non-starter. A requirement to 
repeatedly wash hands is distressing where water is unavailable and soap is unaffordable. 
Unfortunately, this means that public health measures in LMICs may be unable to shield their 
health care systems from a rapid influx of COVID-19 patients.  
 
Shifting the focus to treatment, many ethical recommendations havemuch attention has focused 
on allocationhow to  allocate of high-tech medical interventions in hospitals for COVID-19 
patients, such as ICU beds, mechanical ventilation and dialysis. Of course, this debate looks 
different from the perspective of the 10 African countries who have no mechanical ventilation 
units2 : the ethical problem disappears, or rather, it becomes another ethical debate about how 
such an appalling situation is even possible. Fortunately, as it has become apparent from settings 
where the might of the pandemic has already been felt, most COVID-19 patients may not need 
the more high-tech approaches. The majority appear to have mild (40%) or moderately severe 
disease (40%) and will likely be responsive to less complex treatments like oxygen, venturi masks, 
nasal prongs, decongestants and expectorants, while ventilators, ICU beds and dialysis machines 
will only be indicated in a minority of the most severe cases.3 The bad news: even if only a small 
percentage of COVID-19 patients need critical care, very many will not receive it due to severe 
shortages of necessary equipment and skilled personnel to provide services. The impact of the 
 
 
COVID-19 pandemic seen on stronger health care systems in Italy, France, Spain and the United 
States does not bode at all well for Africa. 
 
Among bioethicists, particularly in high-income countries, the pandemic has sparked a debate 
about fair allocation of scarce resources, resulting in a substantial number of rapidly issued 
recommendations and decision aids4,5,6,7,8. While these are not explicitly intended for global use, 
their context of applicability is not specifiedSuch directives have traditionally been influential in 
LMICs9. But, for reasons indicated below, contextual considerations are critical if ethics guidance 
is to be meaningful.  
 
Most bioethics frameworks emerging from high income countries recommend that scarce 
medical resources be allocated in ways that maximize benefits, i.e. that maximize the number of 
lives saved and improvements in patients’ years of post-treatment life.  Some claim there is 
considerable agreement on these criteria among experts and they can be ethically defended on 
both utilitarian (best overall outcomes) and non-utilitarian (value of human life) grounds. In 
practice, this means prioritizing scarce resources to patients likely to recover and with a 
reasonable life expectancy. These criteria are appealing in that they look impartial and 
biomedical, i.e. determinations based on clinical examinations and prognoses. As Schmidt argues, 
this is not true on closer inspection.10 Given the social determinants of health, those who are 
disadvantaged in society are disproportionately unhealthy, and therefore in emergency care are 
less likely to recover and less likely to have a reasonable life-expectancy post-treatment. In LMICs, 
unless social determinants of health are taken into account in designing COVID-19 allocation 
approaches, those who are worst-off may be least likely to access needed care, compounding 
social injustice. And the elites in those societies, infamous for flying abroadto Paris or New York 
to avoid their own health systems when they get sick, could come out on top yet again.  
 
It may well be that, in LMICs, you cannot take a utilitarian approach without doing further 
damage to those worst off. Saving the most lives with the most potential post-treatment years 
in the COVID-19 context should involve thinking beyond the 5% of the population needing 
mechanical ventilation and ICU beds, and investing in prevention and simpler, less expensive and 
skills-intensive treatments (like oxygen) that can benefit the majority of patients. This includes 
targeted interventions beyond health care institutions such as identification of cases by 
community health workers and mobile clinics, especially since many sick and exposed persons 
will not present to hospitals and clinics, for a variety of reasons.11  Sicker patients in need of more 
intensive treatment will likely be in the same boat as most patients with chronic kidney disease 
in economically very deprived settings, i.e. out of luck. This may be what ‘fair allocation’ will look 
like, though that might not be the best choice of words.   
 
There are debates about whether allocating scarce COVID-19 resources to those most likely to 
recover and who have a reasonable post-treatment life expectancy unfairly favors youth over the 
aged.12 It is interesting to think about the age question from a LMIC perspective. On the one 
hand, many African countries are predominantly young; this could be advantageous in the face 
of a virus that disproportionately threatens older persons. But there is another way of putting it: 
those in the 65 and up age range in LMICs are relatively few, because life-expectancy in most of 
 
 
these countries is low. For example, in the Democratic Republic of Congo, life expectancy is 61 
years; in Nigeria, it is 60.4 years.13. When applied to older CongoleseConglose or Nigerian COVID-
19 patients, it is unclear what ‘reasonable life expectancy post-treatment’ would even mean. 
Does it refer to ‘locally reasonable’? Is ‘reasonable’ the right word?  
 
Emerging bioethics guidance also recommends treating COVID-19 and non-COVID patients 
equitably. While this principle may be suitable for well-resourced healthcare settings, it is not 
clear how it could be implemented in low-income settings faced with an acute public health 
emergency while already being barely able or unable to meet non-COVID medical demand. What 
is more realistic, but comes at an ethical cost, is the short-term prioritization of COVID-19 patients 
with acute illness over non-COVID-19 patients who have chronic, potentially less reversible 
conditions like chronic pulmonary disease with poor outcomes or terminal malignancy. Arguably, 
there is an ethical imperative to shift care priorities and human resources in health care 
institutions when the community is faced with an acute public health emergency. In many 
settings, elective surgeries have already been postponed, and patients with chronic illness have 
been discharged from hospitals to make beds available and the number of critical care beds has 
been increased in proportion to the anticipated demand from COVID-19. Similarly, in LMICs, 
doctors usually restricted to non-COVID-19 specialities will be or have been re-deployed to assist 
in COVID-19 wards, emergency rooms and critical care environments. The ethical cost collateral 
damage of these shifts is (further) neglect, at least in the short term, of patients with serious non-
COVID health conditions.14  
 
Most prioritization frameworks also recommend that frontline health care workers be given 
priority in scarce resource allocation decision-making on two grounds: because they have 
exposed themselves to heightened risk to help others (reciprocity), and because they could 
continue to assist in the COVID-19 response (utility) post-recovery. One could argue that 
reciprocity extends to all personnel, including administrative staff and cleaners, because they 
make patient care possible and are placed at heightened risk relative to the general population.15 
However, in sub-Saharan African settings prioritization may only be possible for frontline health 
workers actively involved in COVID-19 patient care. This policy may be ethically defensible given 
the risks they face (globally, many frontline health care workers acquired COVID-19 and have 
died) and the shortage of highly skilled critical care staff in most African countries.  
 
If SARS-CoV-2 infections rise dramatically in sub-Saharan Africa, the main imperative will be to 
save who can be saved with what few resources are available to lessen the damage to communal 
life. It will not be pretty. Ethical recommendations imported from high-income countries (and 
even international agencies)16 will be of limited relevance; what is also needed is guidance 
informed by how scarcity decisions have been made in LMICs for decades, which are responsive 
to current circumstances, and embody shared cultural values and are developed through a 
transparent, community-engaging process. Short of that, how prioritizationHow allocation 
unfolds will less likely rely on complex allocation schemes emphasizing high-tech critical care, 
and more likely depend on the judgments of experienced African doctors as they distinguish 
between those needing symptomatic treatment including oxygen and those to be triaged to 
palliative care. Perhaps more than elsewhere, health care providers in LMICs during the COVID-
 
 
19 crisis could find themselves regularly confronted within what Lisa Tessman calls ‘moral 
failure’: situations in which avoiding moral wrong is impossible. Even then, it is up to local 
bioethicists to makes sense of what unfolds, and to bear witness. 
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